240 related articles for article (PubMed ID: 18991580)
1. High throughput ADME screening: practical considerations, impact on the portfolio and enabler of in silico ADME models.
Hop CE; Cole MJ; Davidson RE; Duignan DB; Federico J; Janiszewski JS; Jenkins K; Krueger S; Lebowitz R; Liston TE; Mitchell W; Snyder M; Steyn SJ; Soglia JR; Taylor C; Troutman MD; Umland J; West M; Whalen KM; Zelesky V; Zhao SX
Curr Drug Metab; 2008 Nov; 9(9):847-53. PubMed ID: 18991580
[TBL] [Abstract][Full Text] [Related]
2. In silico ADME-Tox modeling: progress and prospects.
Alqahtani S
Expert Opin Drug Metab Toxicol; 2017 Nov; 13(11):1147-1158. PubMed ID: 28988506
[TBL] [Abstract][Full Text] [Related]
3. Preclinical pharmacokinetics: an approach towards safer and efficacious drugs.
Singh SS
Curr Drug Metab; 2006 Feb; 7(2):165-82. PubMed ID: 16472106
[TBL] [Abstract][Full Text] [Related]
4. In silico approaches for predicting ADME properties of drugs.
Yamashita F; Hashida M
Drug Metab Pharmacokinet; 2004 Oct; 19(5):327-38. PubMed ID: 15548844
[TBL] [Abstract][Full Text] [Related]
5. High-throughput screening approaches for investigating drug metabolism and pharmacokinetics.
Roberts SA
Xenobiotica; 2001; 31(8-9):557-89. PubMed ID: 11569526
[TBL] [Abstract][Full Text] [Related]
6. High-throughput and in silico techniques in drug metabolism and pharmacokinetics.
van de Waterbeemd H
Curr Opin Drug Discov Devel; 2002 Jan; 5(1):33-43. PubMed ID: 11865671
[TBL] [Abstract][Full Text] [Related]
7. Pharmacokinetic properties and in silico ADME modeling in drug discovery.
Honório KM; Moda TL; Andricopulo AD
Med Chem; 2013 Mar; 9(2):163-76. PubMed ID: 23016542
[TBL] [Abstract][Full Text] [Related]
8. Metabolic stability for drug discovery and development: pharmacokinetic and biochemical challenges.
Masimirembwa CM; Bredberg U; Andersson TB
Clin Pharmacokinet; 2003; 42(6):515-28. PubMed ID: 12793837
[TBL] [Abstract][Full Text] [Related]
9. Two-dimensional (2D) in silico models for absorption, distribution, metabolism, excretion and toxicity (ADME/T) in drug discovery.
Khakar PS
Curr Top Med Chem; 2010; 10(1):116-26. PubMed ID: 19929825
[TBL] [Abstract][Full Text] [Related]
10. In silico prediction of ADME properties: are we making progress?
Beresford AP; Segall M; Tarbit MH
Curr Opin Drug Discov Devel; 2004 Jan; 7(1):36-42. PubMed ID: 14982146
[TBL] [Abstract][Full Text] [Related]
11. In silico prediction of cytochrome P450-mediated drug metabolism.
Zhang T; Chen Q; Li L; Liu LA; Wei DQ
Comb Chem High Throughput Screen; 2011 Jun; 14(5):388-95. PubMed ID: 21470181
[TBL] [Abstract][Full Text] [Related]
12. Strategy of utilizing in vitro and in vivo ADME tools for lead optimization and drug candidate selection.
Balani SK; Miwa GT; Gan LS; Wu JT; Lee FW
Curr Top Med Chem; 2005; 5(11):1033-8. PubMed ID: 16181128
[TBL] [Abstract][Full Text] [Related]
13. ADME-Tox in drug discovery: integration of experimental and computational technologies.
Yu H; Adedoyin A
Drug Discov Today; 2003 Sep; 8(18):852-61. PubMed ID: 12963322
[TBL] [Abstract][Full Text] [Related]
14. The importance of HT-ADME in drug discovery.
Morgan D
Bioanalysis; 2011 Nov; 3(21):2385-7. PubMed ID: 22074279
[TBL] [Abstract][Full Text] [Related]
15. Role of ADME characteristics in drug discovery and their in silico evaluation: in silico screening of chemicals for their metabolic stability.
Gombar VK; Silver IS; Zhao Z
Curr Top Med Chem; 2003; 3(11):1205-25. PubMed ID: 12769701
[TBL] [Abstract][Full Text] [Related]
16. Applications of high-throughput ADME in drug discovery.
Kassel DB
Curr Opin Chem Biol; 2004 Jun; 8(3):339-45. PubMed ID: 15183334
[TBL] [Abstract][Full Text] [Related]
17. Can the Internet help to meet the challenges in ADME and e-ADME?
Van de Waterbeemd H; De Groot M
SAR QSAR Environ Res; 2002; 13(3-4):391-401. PubMed ID: 12184380
[TBL] [Abstract][Full Text] [Related]
18. From in vivo to in vitro/in silico ADME: progress and challenges.
Van de Waterbeemd H
Expert Opin Drug Metab Toxicol; 2005 Jun; 1(1):1-4. PubMed ID: 16922647
[TBL] [Abstract][Full Text] [Related]
19. In-silico ADME models: a general assessment of their utility in drug discovery applications.
Gleeson MP; Hersey A; Hannongbua S
Curr Top Med Chem; 2011; 11(4):358-81. PubMed ID: 21320065
[TBL] [Abstract][Full Text] [Related]
20. In silico predictions of ADME-Tox properties: drug absorption.
Geerts T; Vander Heyden Y
Comb Chem High Throughput Screen; 2011 Jun; 14(5):339-61. PubMed ID: 21470183
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
